1. Buzoni-Gatel D, Lepage AC, Dimier-Poisson IH, Bout DT, Kasper LH. Adoptive transfer of gut intraepithelial lymphocytes protects against murine infection with
Toxoplasma gondii.
J Immunol 1997;158:5883-5889.
2. Chai JY, Kook J, Guk SM, Chang YP, Yun CK. Experimental infection of murine splenic lymphocytes and granulocytes with
Toxoplasma gondii RH tachyzoites.
Korean J Parasitol 1997;35:79-85.
3. Chardes T, Velge-Roussel F, Mevelec P, Mevelec M-N, Bozoni-Gatel D, Bout D. Mucosal and systemic cellular immune responses induced by
Toxoplama gondii antigens in cyst orally infected mice.
Immunology 1993;78:421-429.
4. Denkers EY, Sher A. Role of natural killer and NK1
+ T-cells in regulating cell-mediated immunity during
Toxoplasma gondii infection.
Biochem Soc Trans 1997;25:699-703.
5. Gazzinelli RT, Hakim FT, Hieny S, Shearer GM, Sher A. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-γ production and protective immunity induced by an attenuated
Toxoplasma gondii vaccine.
J Immunol 1991;146:286-293.
6. Gazzinelli RT, Wysocka M, Hieny S, et al. In the absence of endogenous IL-10, mice acutely infected with
Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ cells and accompanied by overproduction of IL-12, IFN-γ, and TNF-α.
J Immunol 1996;157:798-805.
7. Johnson AM. Strain-dependent, route of challenge-dependent, murine susceptibility to toxoplasmosis.
Z Parasitenkd 1984;70:303-309.
8. Kasper LH. Toxoplasma infection. Harrison's principles of internal medicine. 1997, 14th ed. New York, USA. McGraw-Hill. pp 1197-1202 .
9. Khan IA, Ely KH, Kasper LH. An antigen specific CD8+ cell clone protects against acute
Toxoplasma gondii infection.
J Immunol 1994;152:1856-1860.
10. Lauier M, Quilici M. Experimental value of
Toxoplasma strain only slightly pathogenic for mice.
Ann Parasitol Hum Comp 1970;45:389-403.
11. Liensenfeld O, Kosek J, Remington JS, Suzuki Y. Association of CD4+ T cell-dependent, interferon-γ-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with
Toxoplasma gondii.
J Exp Med 1996;184:597-607.
12. McLeod R, Eisenhauer P, Mack D, Brown C, Filice G, Spitalny G. Immune responses associated with early survival after peroral infection with
Toxoplasma gondii.
J Immunol 1989;142:3247-3255.
13. Reiner SL, Zheng S, Corry DB, Locksley RM. Constructing polycompetitor cDNAs for quantitative PCR.
J Immunol Methods 1993;165:37-46.
14. Roberts CW, Cruickshank SM, Alexander J. Sex-determined resistance to
Toxoplasma gondii is associated with temporal differences in cytokine production.
Infect Immun 1995;63:2549-2555.
15. Sayles PC, Johnson LL. Exacerbation of toxoplasmosis in neutrophil-depleted mice. Nat Immun 1996-1997;15:249-258.
16. Sumyuen MH, Garin YJF, Derouin F. Early kinetics of
Toxoplasma gondii infection in mice infected with orally with cysts of an avirulent strain.
J Parasitol 1995;81:327-329.
17. Suzuki Y, Conley FK, Remington JS. Treatment of toxoplasmic encephalitis in mice with recombinant gamma interferon.
Infect Immun 1990;58:3050-3055.
18. Suzuki Y, Orellana MA, Schreiber RD, Remington JS. Interferon-γ : the major mediator of resistance against
Toxoplasma gondii.
Science 1988;240:516-518.